GlassScriptPhysician profile
Tiffany Degree
NPI 1841905155
$1,606.94
in general payments reported to CMS, 2019-2025
16 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $576 · 2024: $889 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.10 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $425.41 | 2023-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $197.15 | 2023-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lundbeck LLC | $183.85 | 2023-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Alkermes, INC. | $157.72 | 2023-2024 | Aristada, Lybalvi |
| Tris Pharma INC | $115.55 | 2023 | Quillivant, Quillichew Er, Dyanavel Xr |
| Abbvie INC. | $114.50 | 2023-2024 | |
| Indivior INC. | $85.89 | 2024 | Perseris, Sublocade |
| Teva Pharmaceuticals USA, INC. | $74.76 | 2023-2024 | Austedo Xr |
| Axsome Therapeutics, INC. | $42.73 | 2023-2024 | Auvelity |
| Braeburn INC. | $39.49 | 2024 | Brixadi |
| Neurocrine Biosciences, INC. | $38.80 | 2023-2024 | Ingrezza |
| Uswm, LLC | $33.90 | 2024 | Lucemyra |
| Idorsia Pharmaceuticals US INC | $27.74 | 2023-2024 | Quviviq |
| Vanda Pharmaceuticals INC. | $26.15 | 2024 | Fanapt, Hetlioz |
| Takeda Pharmaceuticals U.S.A., INC. | $22.95 | 2024 | Trintellix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $20.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Degree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.